Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George S Vassiliou

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Blood|August 27, 2016
JAK2 V617F clonal disorders: fate or chance?George S Vassiliou
Blood|December 20, 2019
The curious incident of TdT-mediated mutations in AMLGeorge S Vassiliou
Blood|July 20, 2019
Triple-mutant AML: too clever by HLF?George S Vassiliou
Nature|August 11, 2017
Therapeutics: Click and discoverGeorge S Vassiliou, Shankar Balasubramanian
The New England Journal of Medicine|June 12, 2024
T-Cell Cancer after CAR T-Cell TherapyEmily Mitchell, George S Vassiliou
Science Translational Medicine|September 25, 2015
Aging as a driver of leukemogenesisThomas McKerrell, George S Vassiliou
Blood|May 1, 2020
Home and away: clonal hematopoiesis in sibling transplantsMargarete A Fabre, George S Vassiliou
Current Opinion in Genetics & Development|May 8, 2019
Genome-scale drop-out screens to identify cancer cell vulnerabilities in AMLFaisal T Basheer, George S Vassiliou
Hemasphere|August 21, 2023
Genetic Predisposition to Clonal HematopoiesisPedro M Quiros, George S Vassiliou
Blood|November 22, 2023
The lifelong natural history of clonal hematopoiesis and its links to myeloid neoplasiaMargarete A Fabre, George S Vassiliou
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Blood|August 27, 2016
JAK2 V617F clonal disorders: fate or chance?George S Vassiliou
Blood|December 20, 2019
The curious incident of TdT-mediated mutations in AMLGeorge S Vassiliou
Blood|July 20, 2019
Triple-mutant AML: too clever by HLF?George S Vassiliou
Nature|August 11, 2017
Therapeutics: Click and discoverGeorge S Vassiliou, Shankar Balasubramanian
The New England Journal of Medicine|June 12, 2024
T-Cell Cancer after CAR T-Cell TherapyEmily Mitchell, George S Vassiliou
Science Translational Medicine|September 25, 2015
Aging as a driver of leukemogenesisThomas McKerrell, George S Vassiliou
Blood|May 1, 2020
Home and away: clonal hematopoiesis in sibling transplantsMargarete A Fabre, George S Vassiliou
Current Opinion in Genetics & Development|May 8, 2019
Genome-scale drop-out screens to identify cancer cell vulnerabilities in AMLFaisal T Basheer, George S Vassiliou
Hemasphere|August 21, 2023
Genetic Predisposition to Clonal HematopoiesisPedro M Quiros, George S Vassiliou
Blood|November 22, 2023
The lifelong natural history of clonal hematopoiesis and its links to myeloid neoplasiaMargarete A Fabre, George S Vassiliou
Pageof 13